Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing strategies in immunotoxicology.

M Pallardy1, S Kerdine, H Lebrec

  • 1Immunotoxicology group, INSERM U461, Faculté de Pharmacie Paris-Sud, Chatenay-Malabry, France. marc.pallardy@cep.u-psud.fr

Toxicology Letters
|February 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide expression screening in the cardiac embryonic stem cell test shows additional differentiation routes that are regulated by morpholines and piperidines.

Current research in toxicology·2022
Same author

Gene regulation by morpholines and piperidines in the cardiac embryonic stem cell test.

Toxicology and applied pharmacology·2021
Same author

Molecular neural crest cell markers enable discrimination of organophosphates in the murine cardiac embryonic stem cell test.

Toxicology reports·2021
Same author

Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation.

Nanotoxicology·2019
Same author

Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy.

Allergy·2018
Same author

Alteration of Nrf2 and Glutamate Cysteine Ligase expression contribute to lesions growth and fibrogenesis in ectopic endometriosis.

Free radical biology & medicine·2017
Same journal

LEF1 regulated CTHRC1 Promotes Silica-Induced Pulmonary Fibrosis through CD44-Dependent Signaling.

Toxicology letters·2026
Same journal

hERG Channel Blockade and Additive Interactions of Magnolol and Honokiol from Magnolia Species.

Toxicology letters·2026
Same journal

Evaluation of dose-dependent hematotoxic effects of celastrol on human blood cells in vitro.

Toxicology letters·2026
Same journal

Environmental pharmaceutical and antibiotic mixtures: An exposomics-guided framework for mechanistic toxicology.

Toxicology letters·2026
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
See all related articles

Developing new immune function assays is crucial for early drug development screening. Utilizing novel probes and parameters like apoptosis and cytokine mRNA expression can identify potential immunotoxic compounds effectively.

Area of Science:

  • Toxicology
  • Immunology
  • Pharmacology

Background:

  • Assessing immunotoxicity is critical for drug safety and development.
  • High-throughput screening generates numerous compounds requiring toxicological evaluation.
  • Existing methods for immune function assays need improvement.

Purpose of the Study:

  • To develop improved immune function assays for screening immunotoxic compounds.
  • To integrate new knowledge on immune system mechanisms into assay development.
  • To facilitate early risk assessment in drug development pipelines.

Main Methods:

  • Utilizing novel probes and parameters for immune function assessment.
  • Incorporating knowledge of apoptosis and cytokine mRNA expression (RT-PCR).

Related Experiment Videos

  • Developing a battery of assays for comprehensive screening.

    • Main Results:

    • Proposed approach allows for improved screening of immunotoxic compounds.
    • New methods enable early identification of potential adverse effects.
    • Enhanced assays support decision-making in drug development.

    Conclusions:

    • Early screening for immunotoxicity is essential for safe drug development.
    • Advanced assays leveraging new biological insights improve compound evaluation.
    • This approach aids in selecting viable drug candidates amidst numerous possibilities.